AN2 Therapeutics presents SOHO 2026 data on epetraborole for polycythemia vera
AN2 Therapeutics presented clinical and translational data supporting epetraborole development for polycythemia vera at the SOHO 2026 annual meeting.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.